ECHO Backpack Leaf Blower Recall Issued Due to Fire Hazard
About 16,000 ECHO backpack leaf blowers have been recalled due to a risk that they may leak fuel and catch fire.
The ECHO backpack blower recall was announced by the U.S. Consumer Product Safety Commission (CPSC) on February 23.
According to the CPSC, the fuel line between the fuel tank and carburetor may have been damaged during assembly. Although there have been no reports of actual incidents or injuries related to the defective backpack blowers, the damage could cause fuel to leak and pose a fire hazard for consumers
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The recall affects ECHO 2-cycle gas powered backpack blowers with model number PB-265L. The affected blowers have serial numbers of P093121 35519 through P093121 50152 and P078110 20732 through P078110 22309.
They are 25.4 cc blowers, come in orange and black and have “ECHO” printed on the pull starter housing and blower tube. The model number is located on a label near the pull starter handle and the serial number is located on a label near the gas filter cap.
The backpack leaf blowers were sold at Home Depot stores and authorized EHCO dealers for about $270 from between August 2011 and January 2012.
The CPSC recommends that consumers immediately stop sing the backpack blowers and return them to an authorized ECHO servicing dealer for a free repair. Consumers with questions can call ECHO at (800) 432-3246 or visit the company’s website at www.echo-usa.com.
Get more articles like this sent directly to your inbox.
"*" indicates required fields
More Top Stories
A federal magistrate judge has ordered Covidien to turn over a large collection of hernia mesh complaint files to plaintiffs as the parties prepare to select potential bellwether test cases for 2025.
Four federal judges have ruled that the second group of Camp Lejeune lawsuits to be prepared for bellwether trials will involve claims of prostate cancer, kidney disease, lung cancer, liver cancer and breast cancer.
A federal judge has scheduled the initial status conference for coordinated GLP-1 RA drug stomach paralysis lawsuit pretrial proceedings for March 14.